Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2015, Article ID 746502, 4 pages
http://dx.doi.org/10.1155/2015/746502
Research Article

Limitations on the Detection Rate of High-Risk HPV by Hybrid Capture 2 Methodology in High Grade Intraepithelial (HSIL) or Atypical Squamous Cells-Cannot Exclude HSIL (ASC-H) Cytological Lesions with Proved CIN2+

Unit of Gynecopathology, Erasme University Hospital-ULB, Brussels, Belgium

Received 31 July 2015; Accepted 26 August 2015

Academic Editor: Ekaterina S. Jordanova

Copyright © 2015 Jean-Christophe Noël and Philippe Simon. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Arbyn, A. Haelens, A. Desomer et al., “Cervical cancer screening program and Human Papillomavirus (HPV) testing: update on HPV primary screening,” KCE Reports 238, Health Technology Assessment (HTA), Belgian Health Care Knowledge (KCE), Brussels, Belgium, 2015. View at Google Scholar
  2. A. R. Giuliano, A. G. Nyitray, A. R. Kreimer et al., “EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection,” International Journal of Cancer, vol. 136, no. 12, pp. 2752–2760, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. X. Catteau, P. Simon, and J. Noël, “Evaluation of the oncogenic human papillomavirus DNA test with liquid-based cytology in primary cervical cancer screening and the importance of the ASC/SIL ratio: a belgian study,” ISRN Obstetrics and Gynecology, vol. 2014, Article ID 536495, 5 pages, 2014. View at Publisher · View at Google Scholar
  4. F. Coutlée, S. Ratnam, A. V. Ramanakumar et al., “Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada,” Journal of Medical Virology, vol. 83, no. 6, pp. 1034–1041, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Halec, L. Alemany, B. Lloveras et al., “Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer,” The Journal of Pathology, vol. 234, no. 4, pp. 441–451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. D. C. Rijkaart, J. Berkhof, L. Rozendaal et al., “Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial,” The Lancet Oncology, vol. 13, no. 1, pp. 78–88, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Leinonen, P. Nieminen, L. Kotaniemi-Talonen et al., “Age-specific evaluation of primary Human Papillomavirus screening vs conventional cytology in a randomized setting,” Journal of the National Cancer Institute, vol. 101, no. 23, pp. 1612–1623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Ronco, P. Giorgi-Rossi, F. Carozzi et al., “Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial,” The Lancet Oncology, vol. 11, no. 3, pp. 249–257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Cuzick, C. Clavel, K.-U. Petry et al., “Overview of the European and North American studies on HPV testing in primary cervical cancer screening,” International Journal of Cancer, vol. 119, no. 5, pp. 1095–1101, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. P. E. Castle, S. de Sanjose, Y.-L. Quiao, J. L. Belinson, E. Lazcano-Ponce, and W. Kinney, “Introduction of human papillomavirus DNA screening in the world: 15 years of experience,” Vaccine, vol. 30, supplement 5, pp. F117–F122, 2012. View at Publisher · View at Google Scholar
  11. J. S. Gibson, “Nucleic acid-based assays for the detection of high-risk human papillomavirus: a technical review,” Cancer Cytopathology, vol. 122, no. 9, pp. 639–645, 2014. View at Publisher · View at Google Scholar
  12. X. Catteau, M. Vanhaeverbeek, and J.-C. Noël, “Importance of the residual volume of the cytological solution for the reproducibility of the hybrid capture 2 high-risk human papillomavirus DNA test,” Acta Cytologica, vol. 56, no. 4, pp. 375–378, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J.-C. Noël, I. Fayt, M. R. Romero Munoz, P. Simon, and C. Engohan-Aloghe, “High prevalence of high-risk human papillomavirus infection among women with Trichomonas vaginalis infection on monolayer cytology,” Archives of Gynecology and Obstetrics, vol. 282, no. 5, pp. 503–505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. F. W. Abdul-Karim, C. N. Powers, J. S. Berek et al., “A typical squamous cells,” in The Bethesda System for Reporting Cervical Cytology, R. Nayar and D. C. Wilbur, Eds., pp. 103–134, 3rd edition, 2015. View at Google Scholar
  15. M. R. Henry, D. K. Russell, R. D. Luff et al., “Epithelial cell abnormalities: squamous,” in The Bethesda System for Reporting Cervical Cytology, R. Nayar and D. C. Wilbur, Eds., pp. 135–192, 3rd edition, 2015. View at Google Scholar
  16. M. Stoler, C. Bergeron, T. J. Colgan et al., “Squamous cell tumours and precursors,” in WHO Classification of Tumours of Female Reproductive Organs, R. J. Kurman, M. L. Carcangiu, C. S. Herrington, and R. H. Young, Eds., pp. 172–198, IARC, Lyon, France, 4th edition, 2014. View at Google Scholar
  17. X. Catteau, P. Simon, and J.-C. Noël, “Detection of high-grade lesions on cell blocks from residual fluids of pap smears diagnosed as low-grade abnormalities: a preliminary pilot study,” Acta Cytologica, vol. 56, no. 3, pp. 247–250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Clavel, M. Masure, J.-P. Bory et al., “Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women,” British Journal of Cancer, vol. 89, no. 12, pp. 1616–1623, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Szarewski, D. Mesher, L. Cadman et al., “Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the predictors 2 study,” Journal of Clinical Microbiology, vol. 50, no. 6, pp. 1867–1873, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Cuzick, L. Cadman, D. Mesher et al., “Comparing the performance of six human papillomavirus tests in a screening population,” British Journal of Cancer, vol. 108, no. 4, pp. 908–913, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Dillner, M. Rebolj, P. Birembaut et al., “Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study,” British Medical Journal, vol. 377, Article ID a1754, 2008. View at Publisher · View at Google Scholar